Seiji Kakiuchi

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Neoadjuvant Chemotherapy

Chronic Lymphocytic Leukemia

Prognostic Factors

Top Venues

Medicina (Kaunas, Lithuania)

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

This page only lists publications with an associated author ORCID identifier.

Publications

Seiji Kakiuchi, Hiroaki Akiyama, Isamu Harima, Ikumi Takagi, Junpei Rikitake, Yoko Kozuki, Mayumi Inaba, Hiroshi Fujiwara, Nozomu Kurose, Sohsuke Yamada, Yasufumi Masaki
Epstein-Barr Virus-Positive Cutaneous and Systemic Plasmacytosis with TAFRO Syndrome-like Symptoms Successfully Treated with Rituximab. Medicina (Kaunas, Lithuania) 59 (2) (2023)
Seiji Kakiuchi, Hiroaki Akiyama, Isamu Harima, Ikumi Takagi, Junpei Rikitake, Yoko Kozuki, Mayumi Inaba, Hiroshi Fujiwara, Nozomu Kurose, Sohsuke Yamada, Yasufumi Masaki
Epstein-Barr Virus-Positive Cutaneous and Systemic Plasmacytosis with TAFRO Syndrome-like Symptoms Successfully Treated with Rituximab. Medicina (Kaunas, Lithuania) 59 (2) (2023)
Seiji Kakiuchi, Hiroaki Akiyama, Isamu Harima, Ikumi Takagi, Junpei Rikitake, Yoko Kozuki, Mayumi Inaba, Hiroshi Fujiwara, Nozomu Kurose, Sohsuke Yamada, Yasufumi Masaki
Epstein-Barr Virus-Positive Cutaneous and Systemic Plasmacytosis with TAFRO Syndrome-like Symptoms Successfully Treated with Rituximab. Medicina (Kaunas, Lithuania) 59 (2) (2023)
Seiji Kakiuchi, Hiroaki Akiyama, Isamu Harima, Ikumi Takagi, Junpei Rikitake, Yoko Kozuki, Mayumi Inaba, Hiroshi Fujiwara, Nozomu Kurose, Sohsuke Yamada, Yasufumi Masaki
Epstein-Barr Virus-Positive Cutaneous and Systemic Plasmacytosis with TAFRO Syndrome-like Symptoms Successfully Treated with Rituximab. Medicina (Kaunas, Lithuania) 59 (2) (2023)
Seiji Kakiuchi, Hiroaki Akiyama, Isamu Harima, Ikumi Takagi, Junpei Rikitake, Yoko Kozuki, Mayumi Inaba, Hiroshi Fujiwara, Nozomu Kurose, Sohsuke Yamada, Yasufumi Masaki
Epstein-Barr Virus-Positive Cutaneous and Systemic Plasmacytosis with TAFRO Syndrome-like Symptoms Successfully Treated with Rituximab. Medicina (Kaunas, Lithuania) 59 (2) (2023)
Seiji Kakiuchi, Kimikazu Yakushijin, Rina Sakai, Koji Kawaguchi, Ako Higashime, Keiji Kurata, Hiroya Ichikawa, Shigeki Nagao, Junpei Rikitake, Naomi Kiyota, Hiroshi Matsuoka, Hironobu Minami
Discontinuation of sorafenib can lead to the emergence of FLT3-ITD-positive acute myeloid leukemia. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 25 (8) (2018)